Gene and cell therapies: market access and funding
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Boca Raton ; London ; New York
CRC Press
2020
|
| Ausgabe: | First edition |
| Schriftenreihe: | Pharmaceuticals, Health Economics and Market Access
|
| Schlagworte: | |
| Beschreibung: | Includes bibliographical references and index 2005 |
| Beschreibung: | xxii, 145 Seiten Illustrationen |
| ISBN: | 9780367483845 9780367408091 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV047560076 | ||
| 003 | DE-604 | ||
| 005 | 20211206 | ||
| 007 | t | ||
| 008 | 211026s2020 xxua||| |||| 00||| eng d | ||
| 020 | |a 9780367483845 |c hardback |9 978-0-367-48384-5 | ||
| 020 | |a 9780367408091 |c paperback |9 978-0-367-40809-1 | ||
| 035 | |a (OCoLC)1289779797 | ||
| 035 | |a (DE-599)BVBBV047560076 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 044 | |a xxu |c XD-US | ||
| 049 | |a DE-634 | ||
| 050 | 0 | |a RB155.8 | |
| 082 | 0 | |a 616/.042 | |
| 084 | |a WG 7400 |0 (DE-625)148616: |2 rvk | ||
| 100 | 1 | |a Hanna, Eve |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Gene and cell therapies |b market access and funding |c Eve Hanna and Mondher Toumi |
| 250 | |a First edition | ||
| 264 | 1 | |a Boca Raton ; London ; New York |b CRC Press |c 2020 | |
| 300 | |a xxii, 145 Seiten |b Illustrationen | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Pharmaceuticals, Health Economics and Market Access | |
| 500 | |a Includes bibliographical references and index | ||
| 500 | |a 2005 | ||
| 650 | 0 | 7 | |a Frischzellentherapie |0 (DE-588)4067560-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmazeutische Technologie |0 (DE-588)4045699-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelwirtschaft |0 (DE-588)4418449-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Gentherapie |0 (DE-588)4296957-8 |2 gnd |9 rswk-swf |
| 653 | 0 | |a Gene therapy | |
| 653 | 0 | |a Cellular therapy | |
| 653 | 0 | |a Medical technology / Evaluation | |
| 653 | 0 | |a Technology assessment / Government policy | |
| 653 | 0 | |a Drug accessibility | |
| 653 | 0 | |a Pharmaceutical biotechnology industry / Marketing / Government policy | |
| 653 | 0 | |a Pharmaceutical biotechnology / Law and legislation | |
| 689 | 0 | 0 | |a Gentherapie |0 (DE-588)4296957-8 |D s |
| 689 | 0 | 1 | |a Frischzellentherapie |0 (DE-588)4067560-9 |D s |
| 689 | 0 | 2 | |a Arzneimittelwirtschaft |0 (DE-588)4418449-9 |D s |
| 689 | 0 | 3 | |a Pharmazeutische Technologie |0 (DE-588)4045699-7 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Toumi, Mondher |e Verfasser |4 aut | |
| 776 | 0 | |z 9780367809201 |c ebook | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-032935529 | ||
Datensatz im Suchindex
| _version_ | 1804182886473007104 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author | Hanna, Eve Toumi, Mondher |
| author_facet | Hanna, Eve Toumi, Mondher |
| author_role | aut aut |
| author_sort | Hanna, Eve |
| author_variant | e h eh m t mt |
| building | Verbundindex |
| bvnumber | BV047560076 |
| callnumber-first | R - Medicine |
| callnumber-label | RB155 |
| callnumber-raw | RB155.8 |
| callnumber-search | RB155.8 |
| callnumber-sort | RB 3155.8 |
| callnumber-subject | RB - Pathology |
| classification_rvk | WG 7400 |
| ctrlnum | (OCoLC)1289779797 (DE-599)BVBBV047560076 |
| dewey-full | 616/.042 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616/.042 |
| dewey-search | 616/.042 |
| dewey-sort | 3616 242 |
| dewey-tens | 610 - Medicine and health |
| discipline | Biologie Medizin |
| discipline_str_mv | Biologie Medizin |
| edition | First edition |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02115nam a2200577 c 4500</leader><controlfield tag="001">BV047560076</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20211206 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">211026s2020 xxua||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780367483845</subfield><subfield code="c">hardback</subfield><subfield code="9">978-0-367-48384-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780367408091</subfield><subfield code="c">paperback</subfield><subfield code="9">978-0-367-40809-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1289779797</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV047560076</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">XD-US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-634</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RB155.8</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616/.042</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">WG 7400</subfield><subfield code="0">(DE-625)148616:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Hanna, Eve</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Gene and cell therapies</subfield><subfield code="b">market access and funding</subfield><subfield code="c">Eve Hanna and Mondher Toumi</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">First edition</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Boca Raton ; London ; New York</subfield><subfield code="b">CRC Press</subfield><subfield code="c">2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xxii, 145 Seiten</subfield><subfield code="b">Illustrationen</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Pharmaceuticals, Health Economics and Market Access</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">2005</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Frischzellentherapie</subfield><subfield code="0">(DE-588)4067560-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazeutische Technologie</subfield><subfield code="0">(DE-588)4045699-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelwirtschaft</subfield><subfield code="0">(DE-588)4418449-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gentherapie</subfield><subfield code="0">(DE-588)4296957-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Gene therapy</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Cellular therapy</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medical technology / Evaluation</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Technology assessment / Government policy</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Drug accessibility</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Pharmaceutical biotechnology industry / Marketing / Government policy</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Pharmaceutical biotechnology / Law and legislation</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Gentherapie</subfield><subfield code="0">(DE-588)4296957-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Frischzellentherapie</subfield><subfield code="0">(DE-588)4067560-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Arzneimittelwirtschaft</subfield><subfield code="0">(DE-588)4418449-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Pharmazeutische Technologie</subfield><subfield code="0">(DE-588)4045699-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Toumi, Mondher</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="776" ind1="0" ind2=" "><subfield code="z">9780367809201</subfield><subfield code="c">ebook</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-032935529</subfield></datafield></record></collection> |
| id | DE-604.BV047560076 |
| illustrated | Illustrated |
| index_date | 2024-07-03T18:27:12Z |
| indexdate | 2024-07-10T09:14:40Z |
| institution | BVB |
| isbn | 9780367483845 9780367408091 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-032935529 |
| oclc_num | 1289779797 |
| open_access_boolean | |
| owner | DE-634 |
| owner_facet | DE-634 |
| physical | xxii, 145 Seiten Illustrationen |
| publishDate | 2020 |
| publishDateSearch | 2020 |
| publishDateSort | 2020 |
| publisher | CRC Press |
| record_format | marc |
| series2 | Pharmaceuticals, Health Economics and Market Access |
| spelling | Hanna, Eve Verfasser aut Gene and cell therapies market access and funding Eve Hanna and Mondher Toumi First edition Boca Raton ; London ; New York CRC Press 2020 xxii, 145 Seiten Illustrationen txt rdacontent n rdamedia nc rdacarrier Pharmaceuticals, Health Economics and Market Access Includes bibliographical references and index 2005 Frischzellentherapie (DE-588)4067560-9 gnd rswk-swf Pharmazeutische Technologie (DE-588)4045699-7 gnd rswk-swf Arzneimittelwirtschaft (DE-588)4418449-9 gnd rswk-swf Gentherapie (DE-588)4296957-8 gnd rswk-swf Gene therapy Cellular therapy Medical technology / Evaluation Technology assessment / Government policy Drug accessibility Pharmaceutical biotechnology industry / Marketing / Government policy Pharmaceutical biotechnology / Law and legislation Gentherapie (DE-588)4296957-8 s Frischzellentherapie (DE-588)4067560-9 s Arzneimittelwirtschaft (DE-588)4418449-9 s Pharmazeutische Technologie (DE-588)4045699-7 s DE-604 Toumi, Mondher Verfasser aut 9780367809201 ebook |
| spellingShingle | Hanna, Eve Toumi, Mondher Gene and cell therapies market access and funding Frischzellentherapie (DE-588)4067560-9 gnd Pharmazeutische Technologie (DE-588)4045699-7 gnd Arzneimittelwirtschaft (DE-588)4418449-9 gnd Gentherapie (DE-588)4296957-8 gnd |
| subject_GND | (DE-588)4067560-9 (DE-588)4045699-7 (DE-588)4418449-9 (DE-588)4296957-8 |
| title | Gene and cell therapies market access and funding |
| title_auth | Gene and cell therapies market access and funding |
| title_exact_search | Gene and cell therapies market access and funding |
| title_exact_search_txtP | Gene and cell therapies market access and funding |
| title_full | Gene and cell therapies market access and funding Eve Hanna and Mondher Toumi |
| title_fullStr | Gene and cell therapies market access and funding Eve Hanna and Mondher Toumi |
| title_full_unstemmed | Gene and cell therapies market access and funding Eve Hanna and Mondher Toumi |
| title_short | Gene and cell therapies |
| title_sort | gene and cell therapies market access and funding |
| title_sub | market access and funding |
| topic | Frischzellentherapie (DE-588)4067560-9 gnd Pharmazeutische Technologie (DE-588)4045699-7 gnd Arzneimittelwirtschaft (DE-588)4418449-9 gnd Gentherapie (DE-588)4296957-8 gnd |
| topic_facet | Frischzellentherapie Pharmazeutische Technologie Arzneimittelwirtschaft Gentherapie |
| work_keys_str_mv | AT hannaeve geneandcelltherapiesmarketaccessandfunding AT toumimondher geneandcelltherapiesmarketaccessandfunding |